This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 11 full-time employees. The firm focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). The betahistine program is in Phase 1 of clinical trials. Other programs in the Company's product pipeline include brimapitide-based AM-111 for the treatment of acute inner ear hearing loss and eskatemine-based Keyzilen (AM-101) for the treatment of acute inner ear tinnitus, both in Phase 3 of clinical trials, as well as AM-102 indicated for tinnitus, undergoing preclinical studies focused on selecting the lead compound. The firm operates through subsidiaries in Switzerland, Ireland and the United States.
Show more...
CEO
Thomas Meyer
Employees
8
Country
CH
Listings
0 Comments
Share your thoughts
FAQ
What is Auris Medical Holding stock price today?▼
The current price of EARS is $3.07 USD — it has decreased by -0.97% in the past 24 hours. Watch Auris Medical Holding stock price performance more closely on the chart.
What is Auris Medical Holding stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Auris Medical Holding stocks are traded under the ticker EARS.
What is Auris Medical Holding market cap?▼
Today Auris Medical Holding has the market capitalization of 39.51M
How many employees does Auris Medical Holding have?▼
As of April 02, 2026, the company has 8 employees.
In which sector is Auris Medical Holding located?▼
Auris Medical Holding operates in the Manufacturing sector.
When did Auris Medical Holding complete a stock split?▼
The last stock split for Auris Medical Holding was on May 01, 2019 with a ratio of 1:20.
Where is Auris Medical Holding headquartered?▼
Auris Medical Holding is headquartered in Zug, CH.